Health TrialsbyHealthPanel

Impact of a Nursing Educational Consultation on the Patient's Adherence to Their Post-stroke Care Plan.

ConditionsStrokePatient Education
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorUniversity Hospital, Bordeaux

About this trial

This prospective, single-center, randomized study will evaluate the impact of implementing an educational nursing consultation at the end of hospitalisation for stroke patients returning home on overall adherence to stroke-related medication during the 4-month follow-up visit.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Patients admitted to the Neurovascular Unit (UNV) of CHCB for ischemic stroke and/or hemorrhagic stroke confirmed by brain imaging and/or TIA with an ABCD2 score >5,

Patients whose discharge orientation is a return home

Age ≥ 18 years

NIHSS < 15

Disqualifiers

Patients admitted for mechanical thrombectomy, outside the Basque Coast Hospital (CHCB)

Rankin score estimated at discharge ≥ 4

Patients requiring assistance from a third party at home for the management of their medication or with stroke follow-up at Prado

Patients placed under protection measures

Trial design

Design model

Parallel

Treatments tested in this trial

  • nursing educational consultation

    Other intervention

    At the end of hospitalization, the patient will receive a nursing education consultation prior to discharge. This consultation will provide personalized information regarding stroke pathology, its mechanisms and etiology, medication treatments, personal vascular risk factors, and the implementation of the care plan (rehabilitation, additional examinations). Discharge documents are provided at the end of this consultation.

Treatment groups

300 Participants
are divided into 2 treatment groups
Group A: standard stroke care pathway GroupNo intervention 0 interventions
Group B: additionnal educational nursing consultation groupActive comparator 1 intervention

Trial outcomes

Primary outcomes

1

Measurement of the proportion of patients with high adherence to their prescribed medications after stroke, upon returning home

The adherence will be evaluate using the 8-item Morisky Medication Adherence Scale (MMAS-8), in both arms. The MMAS-8 will provide an overall assessment of all treatments prescribed in the context of stroke. This score is an 8-item self-administered questionnaire, validated in French, intended for adults, which allows patients to be classified into three groups according to their score: * High adherence: score = 8 * Moderate adherence: score from 6 to \<8 * Low adherence: score \< 6 For the primary analysis, adherence will be considered as a binary outcome: high adherence versus moderate or low adherence.

Time frame
4 months

Secondary outcomes

1

Description of the specfic therapeutic adherence

Description of medication adherence by therapeutic class compared with prescriptions at hospital discharge, in both groups, based on patient self-report.

Time frame
4 & 12 months
2

Evaluation of Patient adherence to the post-stroke care plan (1)

Evaluation of the proportion of patients attending the post-stroke follow-up consultation in both groups.

Time frame
4 & 12 months
3

Evaluation of Patient adherence to the post-stroke care plan (2)

Evaluation of the proportion of rehabilitation interventions completed (physiotherapy and/or speech therapy), calculated relative to what was prescribed at hospital discharge (number of completed prescriptions per patient / number of prescribed rehabilitation interventions), in both groups, based on patient self-report.

Time frame
4 & 12 months
4

Evaluation of Patient adherence to the post-stroke care plan (3)

Evaluation of the proportion of prescribed post-stroke complementary investigations completed, calculated relative to what was prescribed at hospital discharge (number of completed tests / number of prescribed tests), in both groups based on patient self-report.

Time frame
4 & 12 months

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

University Hospital, Bordeaux

Lead sponsor

Centre Hospitalier de la côte Basque

Collaborator

Source ClinicalTrials.gov
Apply now